10-Q
Quarterly Report
VITASPRING BIOMEDICAL CO., LTD.
CIK: 1697884
File #: 333-216645
Balance Sheet
29 line items · 2 periods
XBRL
| Item | Oct 31, 2025 | Jan 31, 2025 |
|---|---|---|
BALANCE SHEETS | ||
ASSETS | ||
CURRENT ASSETS | ||
Cash | 1,960 | 272 |
Other Non-Operating Current Assets | 7,698 | 0 |
Other Non-Operating Current Assets | 169 | 0 |
Total current assets | 9,827 | 272 |
LONG-TERM ASSET | ||
Property, Plant and Equipment | 6,638 | 14,106 |
Total long-term asset | 6,638 | 14,106 |
Total assets | 16,465 | 14,378 |
LIABILITIES AND STOCKHOLDERS' DEFICIT | ||
CURRENT LIABILITIES | ||
Accounts Payable | 2,411,000 | 2,411,000 |
Accounts Payable | 609,352 | 494,751 |
Taxes Payable | 342,879 | 313,722 |
Advances from related party | 1,002,338 | 810,105 |
Total current liabilities | 4,365,569 | 4,029,578 |
Total liabilities | 4,365,569 | 4,029,578 |
COMMITMENTS AND CONTINGENCIES | 0 | 0 |
STOCKHOLDERS' DEFICIT | ||
Total Stockholders' Equity | 20,703 | 20,703 |
Total Stockholders' Equity | 1,245,600 | 1,245,600 |
Total Stockholders' Equity | (5,615,407) | (5,281,503) |
Total stockholders' deficit | (4,349,104) | (4,015,200) |
Accumulated Deficit | (5,615,407) | (5,281,503) |
Additional Paid-In Capital | 1,245,600 | 1,245,600 |
Common Stock | 20,703 | 20,703 |
Total liabilities and stockholders' deficit | 16,465 | 14,378 |